Results 111 to 120 of about 19,474 (223)

Supplementary Figure 1 from Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer

open access: yes
Supplementary Figure S1 illustrates the cytotoxic effects of GD2-CARTs (GD2-2840z-CARTs, GD2-28z-CARTs, and GD2-BBz-CARTs) and control T cells on GD2+ tumor cells through in vitro 51Cr release assays.
Takaharu Kimura (18136118)   +13 more
core   +1 more source

Novel anti-GD2 CAR-T cells exhibit superior cytotoxicity against neuroblastoma

open access: yesEuropean Journal of Inflammation, 2020
Treatment of high-risk paediatric neuroblastoma represents an unmet clinical need. Chimeric antigen receptor-modified T cell (CAR-T) therapy is a promising treatment option, but there exist some challenges regarding specificity and potency.
Cheng ji   +11 more
doaj   +1 more source

Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells

open access: yesJournal of Hematology & Oncology
Sarcomas are rare, mesenchymal tumors, representing about 10–15% of all childhood cancers. GD2 is a suitable target for chimeric antigen receptor (CAR) T-cell therapy due to its overexpression in several solid tumors.
Michele Pezzella   +29 more
semanticscholar   +1 more source

Staff Confidence and Barriers to Complex Clinical Communication in Nursing Homes: A Convergent Mixed‐Methods Study

open access: yesJournal of Clinical Nursing, EarlyView.
ABSTRACT Aim To describe all nursing home staff members' confidence in engaging in complex clinical communication with residents and family carers, and to explore factors affecting their attitudes. Methods A convergent mixed‐methods study used questionnaires (n = 288) and 15 group‐based discussions involving 278 professionals across nine nursing homes ...
Silvia Gonella   +17 more
wiley   +1 more source

FIGURE 1 from Rejuvenated iPSC-derived GD2-directed CART Cells Harbor Robust Cytotoxicity Against Small Cell Lung Cancer

open access: yes
Generation of GD2-CARTs. A, GD2 expression by NSCLC cell line (negative control) and by four SCLC cell lines (red), with isotype control (blue). The plots represent three independent experiments.
Takaharu Kimura (18136118)   +13 more
core   +1 more source

Crucial roles of exosomes secreted from ganglioside GD3/GD2-positive glioma cells in enhancement of the malignant phenotypes and signals of GD3/GD2-negative glioma cells [PDF]

open access: yes
Neuroectoderm-derived tumors characteristically express gangliosides such as GD3 and GD2. Many studies have reported that gangliosides GD3/GD2 enhance malignant phenotypes of cancers.
Kambe, Mariko   +13 more
core   +1 more source

Tuning Coordination Chemistry and Composition of Metal–Organic Frameworks for Efficient Hydrogen Production

open access: yesCarbon Neutralization, Volume 5, Issue 6, November 2026.
The graphical abstract indicates various photo‐ and photoelectrochemical green methods to produce hydrogen energy using MOF‐based assemblies. Different aspects of MOFs, including organic linkers, metal nodes and their advantage as guest support, are explored thoroughly.
Muhammad Ashraf   +16 more
wiley   +1 more source

CD24 Positive Nucleus Pulposus Cells in Adult Human Intervertebral Discs Maintain a More Notochordal Phenotype Than GD2 Positive Cells

open access: yesJOR Spine
Background Notochordal cells (NCs) present in the nucleus pulposus (NP) of the developing human intervertebral disc (IVD) disappear during the first decade of life.
Andra‐Maria Ionescu   +5 more
doaj   +1 more source

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.

open access: yesPLoS Pathogens, 2017
A genital herpes vaccine is urgently needed to prevent pain and suffering, reduce the incidence of neonatal herpes, and decrease the risk of HIV acquisition and transmission that accompanies genital infection.
Sita Awasthi   +7 more
doaj   +1 more source

An Orthotopic Xenograft Model for Preclinical Evaluation of CAR T Cell Therapy in Glioblastoma

open access: yesCurrent Protocols, Volume 6, Issue 11, November 2026.
Abstract Glioblastoma (GBM) is the most lethal primary brain tumor in adults, and despite intensive research efforts, effective therapeutic breakthroughs remain elusive. Consequently, the standard of care has remained largely unchanged for nearly 30 years, underscoring the need for robust preclinical models to evaluate experimental therapies.
Julian Hübner   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy